Thank you for your interest in viewing the Precision Medicine Program Data & Update webinar!
February 9, 2016
This is a public webinar discussing the world's first precision medicine program in ALS. It will include a presentation from our chief scientific officer and CEO, Steve Perrin, Ph.D. who will show data and discuss findings to date. Discussion will be a key part of this presentation. More than 250 people are enrolled in this program - thank you to all of them! We are excited to show you early data from this program as part of our commitment to efficency, transparency and innovation as we discovery and develop effective treatments and cures for ALS.
Please provide the following information so we can continue to make our Webinars relevant for the entire ALS community
* = Required Fields
Register now for our upcoming webinar on May 10th at 6pm: FDA approves Radicava - What do we need to know?
#WHATWOULDYOUGIVE to #ENDALS?
For ALS Awareness Month, join our #InThreeWords campaign on social media.
You can be a hero and give to ALS TDI to help us get more promising treatments out of our lab and into people living with ALS.
November 27 is
You've taken the challenge, now help
move promising treatments out of our
lab and into people living with ALS.
The 2018 Combined Federal Campaign has officially launched!
Help us continue to move more potential treatments into the clinic!
Stay up to date with ALS TDI by subscribing to our newsletter today!
Join the Ride to #EndALS